CHEMBIO DIAGNOSTICS, INC. - FORM 10-Q - EX-32 - SECTION 906 CERT - May 9, 2017

Attached files

file filename
EX-10.5 - EXHIBIT 10.5 EMPLOYMENT AGREEMENT - AVIJIT ROY - CHEMBIO DIAGNOSTICS, INC.exhibit10_5.htm
EX-10.4 - EXHIBIT 10.5 EMPLOYMENT AGREEMENT - MAGENTRIEN VAJURAM - CHEMBIO DIAGNOSTICS, INC.exhibit10_4.htm
EX-10.1 - EXHIBIT 10.1 EMPLOYMENT CONTRACT - JOHN SPERZEL - CHEMBIO DIAGNOSTICS, INC.exhibit10_1.htm
EX-31.2 - CFO CERT - CHEMBIO DIAGNOSTICS, INC.ex31_2q.htm
EX-31.1 - CEO CERT - CHEMBIO DIAGNOSTICS, INC.ex31_1q.htm
10-Q - FORM 10-Q FIRST QUARTER 2017 - CHEMBIO DIAGNOSTICS, INC.form10q.htm
EXHIBIT 32

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q (the "Report") of Chembio Diagnostics, Inc. (the "Company") for the quarter ended March 31, 2017, each of the undersigned John J. Sperzel III, the Chief Executive Officer of the Company, and Richard J. Larkin, the Chief Financial Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of the undersigneds' knowledge and belief:

(1) This Form 10-Q for the quarter ended March 31, 2017 fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in this Form 10-Q for the quarter ended March 31, 2017 fairly presents, in all material respects, the financial condition and results of operations of Chembio Diagnostics, Inc. for the periods presented therein.



Dated:  May 9, 2017 /s/ John J. Sperzel III
John J. Sperzel III
Chief Executive Officer


Dated:  May 9, 2017 /s/ Richard J. Larkin
Richard J. Larkin
Chief Financial Officer


CHEMBIO DIAGNOSTICS, INC. Reports